Journal Editors Press For More Disclosure Of Underlying Trial Data
This article was originally published in The Gray Sheet
Executive Summary
The International Committee of Medical Journal Editors is collecting feedback on its plan to require clinical trial investigators to disclose patient-level data as a condition of publication.
You may also be interested in...
Clinical Trial Transparency Gets A Boost With J&J Agreement, IOM Report
Johnson & Johnson's device and diagnostic clinical trial data is now available to independent researchers via Yale University’s Open Data Access (YODA) Project, announced the same day as an Institute of Medicine report mapping out strategies for clinical trial data-sharing.
Infuse Open-Access Project A Model For The Future? Medtronic Thinks So
Two independent analyses published last week on Medtronic’s Infuse biologic bone graft do not paint a positive picture for the device, but they do represent an important model for the future of open-access data analysis, both Medtronic and academic proponents say.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.